
Portfolio analysis & due diligence for finished medicinal products
The market for pharmaceutical products is changing more frequently than in other industries. Changing market requirements, supplier structures and regulatory requirements make regular reviews of products and processes necessary to ensure they are up-to-date and cost-effective. We review the future viability of your product portfolio, uncover potential and support you in operating successfully in the EU market.
For example, we determine the possibilities and requirements for registering, producing, importing and marketing a finished medicinal product that has already been approved in a third country for a new target country.
Product Due Diligence
An up-to-date and realistic assessment of the market value of pharmaceutical products and the special manufacturing features is the first and most important step in the context of an acquisition or sale intention in order to be able to make well-founded decisions - and to create a good, valuable basis for negotiation. In our careful due diligence assessments, we analyze the status quo, the potential and the risks of your products and determine an appropriate market value.
Our assessment includes the entire value chain of your product. With our expertise in making pharmaceutical production processes more reliable, leaner and therefore more economical, we are also happy to support you in the regulatory optimization of your manufacturing processes in order to make specific products attractive for future considerations.
We discover the potential of medicinal products and medical devices:
Site and process optimization
Production transfer
Sparring partner
Do you have any questions about the products and services of Bensmann GmbH?
Phone +49 151 2398 1568
e-mail info@bensmanngmbh.de
or via Contact form